These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31564016)

  • 1. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis.
    Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B
    Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Monocyte Chemotactic Protein (MCP)-2 as Biomarker in Response to PE35/PPE68 Proteins: A Promising Diagnostic Method for the Discrimination of Active and Latent Tuberculosis.
    Mamishi S; Pourakbari B; Sadeghi RH; Marjani M; Mahmoudi S
    Protein Pept Lett; 2019; 26(4):281-286. PubMed ID: 30663558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon Gamma Release Assay in response to PE35/PPE68 proteins: a promising diagnostic method for diagnosis of latent tuberculosis.
    Mahmoudi S; Pourakbari B; Mamishi S
    Eur Cytokine Netw; 2017 Mar; 28(1):36-40. PubMed ID: 28840843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
    Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
    Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis.
    Hong JY; Jung GS; Kim H; Kim YM; Lee HJ; Cho SN; Kim SK; Chang J; Kang YA
    Int J Infect Dis; 2012 Dec; 16(12):e855-9. PubMed ID: 22959355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population.
    Wang S; Diao N; Lu C; Wu J; Gao Y; Chen J; Zhou Z; Huang H; Shao L; Jin J; Weng X; Zhang Y; Zhang W
    PLoS One; 2012; 7(12):e51338. PubMed ID: 23272100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of interferon-γ-induced protein 10 for diagnosing latent tuberculosis infection: a systematic review and meta-analysis.
    Qiu X; Tang Y; Yue Y; Zeng Y; Li W; Qu Y; Mu D
    Clin Microbiol Infect; 2019 Jun; 25(6):667-672. PubMed ID: 30553864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.
    Blauenfeldt T; Heyckendorf J; Graff Jensen S; Lange C; Drabe C; Hermansen TS; de Thurah L; Lillebaek T; Eugen-Olsen J; Seersholm N; Hoff S; Bonde J; Ruhwald M
    PLoS One; 2014; 9(9):e105628. PubMed ID: 25184553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
    Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
    Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection.
    Estévez O; Anibarro L; Garet E; Pallares Á; Pena A; Villaverde C; Del Campo V; González-Fernández Á
    PLoS One; 2020; 15(7):e0235859. PubMed ID: 32687494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda.
    Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A
    PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-18/IL-37/IP-10 signalling complex as a potential biomarker for discriminating active and latent TB.
    Wawrocki S; Seweryn M; Kielnierowski G; Rudnicka W; Wlodarczyk M; Druszczynska M
    PLoS One; 2019; 14(12):e0225556. PubMed ID: 31821340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection.
    Pathakumari B; Anbarasu D; Parthasarathy RT; Raja A
    Tuberculosis (Edinb); 2015 Dec; 95(6):736-743. PubMed ID: 26546406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.